News About: Pharm. Industry
Special contributions: Prospect for domestic pharmaceutical industry in 2009
The following article is contributed by IBK Securities Research Center. – Ed. -
Korea's economy is headed into a tough new year, with policymakers desperately trying to shield it from the headwinds of a worldwide ...
Park named head of health and medical policy bureau
Park Ha-jung, 52, has been named as head of health and medical policy bureau, the Ministry for Health, Welfare and Family Affairs said on December 30.
“Park is a health and medical specialist in our ministry. We ex...
Daehan Pharm conducts shakeup
Daehan Pharm has recently announced changes to its top management.
Following the reshuffle, Daihan appointed Lee Dong-il, ex-president of Hanil Pharm, as its new chief executive from January 1, 2009 in what is seen...
Ilyang, Nutra to join forces in new drug R&D
Ilyang Pharm and Nutra R&BT Inc., a local biopharmaceutical company, have agreed to join hands to develop new for treatment of arthritis, stroke and atopic disease, including antioxidants so that they can stay competi...
Kang named COM of Novartis headquarters
Switzerland based Novartis Inc. appointed Kang Jae-hoon as its clinical operation manager (COM), responsible for overall business of multinational clinical trials in International Clinical Research Operations (ICRO) a...
Pfizer Korea under fire over payment terms
Pharmaceutical giant Pfizer is accused of flexing its muscle by demanding more excessive payment terms, such as bank’s payment guarantee over bonds issued by hospitals, inviting criticism from domestic drug wholesaler...
Handok joins up with Orient Europharma over Loramyc
Handok Pharmaceuticals announced on December 24 that it has signed a licensing agreement with Taiwan’s Orient Europharma Co. Ltd. for the exclusive distribution rights in Taiwan, Singapore and Malaysia of Loramyc muco...
Mvix to use unique hologram on the pack
SK Chemicals said on December 29 that it will make use of a unique hologram on the pack of Mvix 100 mg (mirodenafil 2HCL 100mg) from January 1, 2009.
The company said that to promote the responsible use of Mvix wor...
Korean drugmakers set eyes on overseas markets
The domestic major pharmaceutical firms, such as Dong-A Pharmaceutical, Yuhan Corporation and Hanmi Pharm, are going all-out to make inroads into foreign countries as the domestic market shows clear signs of reaching ...
Pharmaceutical firms to raise R&D spending by 10% in 2012
Domestic pharmaceutical firms plan to hike spending on research and development (R&D) by 10 percent over their sales revenue from six percent this year.
In his New Year message, the Korea Pharmaceutical Manufacture...
